STOCK TITAN

Rocket Pharmaceuticals Warrant (RCKTW) Stock Price, News & Analysis

RCKTW NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
95 206 sessions, September 2, 2025 to September 2, 2026
Largest daily move
+1900% close of September 2, 2026
1-year change
-95% closing prices, September 2, 2025 to September 2, 2026

Company Description

Rocket Pharmaceuticals Warrant (NASDAQ: RCKTW) is classified in the pharmaceutical preparations industry.

RCKTW has declined 95.0% over the past year. The last closing price was $0.0020.

For FY2025, Rocket Pharmaceuticals Warrant reported revenue of $0 with net income of -$223.1M and diluted earnings per share of -$2.01.

This page collects what Stock Titan holds for RCKTW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
-
-
Last updated:
-95%
Performance 1 year

Rocket Pharmaceuticals Warrant (RCKTW) closed at $0.0020 on September 2, 2026. Over the past 12 months, the price has lost 95.0%.

See what a $1,000 investment in RCKTW would be worth today

RCKTW Metrics & Rankings

Month to date
+400.0%
View ranking
YTD
-91.8%
View ranking

Price returns through September 2, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

No recent news available for RCKTW.

SEC Filings

Rocket Pharmaceuticals Warrant has filed 5 recent SEC filings, including 2 Form 144, 1 Form 4, 1 Form 25-NSE, 1 Form 8-K. The most recent filing was submitted on September 11, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all RCKTW SEC filings →

Financial Highlights

operating income reached -$231.7M, and net income was -$223.1M. Diluted earnings per share stood at -$2.01. The company generated -$190.0M in operating cash flow. With a current ratio of 6.38, the balance sheet reflects a strong liquidity position.

$0
Revenue (FY2025)
-$223.1M
Net Income (FY2025)
-$190.0M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Rocket Pharmaceuticals Warrant (RCKTW) currently stands at 49.5 thousand shares, up 0.8% from the previous reporting period. Since September 2025, short interest has increased by 4652.9%.

Days to Cover History

Last 12 Months

Days to cover for Rocket Pharmaceuticals Warrant (RCKTW) currently stands at 1.4 days, up 40% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 40% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 29.8 days.

RCKTW Company Profile & Sector Positioning

Rocket Pharmaceuticals Warrant (RCKTW) and is listed on the NASDAQ.

Frequently Asked Questions

What is the current stock price of Rocket Pharmaceuticals Warrant (RCKTW)?

The current stock price of Rocket Pharmaceuticals Warrant (RCKTW) is $0.002 as of September 2, 2026.

What is the revenue of Rocket Pharmaceuticals Warrant (RCKTW) stock?

The FY2025 revenue of Rocket Pharmaceuticals Warrant (RCKTW) is $0, from its most recent completed fiscal year.

What is the net income of Rocket Pharmaceuticals Warrant (RCKTW)?

The FY2025 net income of Rocket Pharmaceuticals Warrant (RCKTW) is -$223.1M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of Rocket Pharmaceuticals Warrant (RCKTW)?

The diluted earnings per share (EPS) of Rocket Pharmaceuticals Warrant (RCKTW) is -$2.01 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of Rocket Pharmaceuticals Warrant (RCKTW)?

The operating cash flow of Rocket Pharmaceuticals Warrant (RCKTW) is -$190.0M. Learn about cash flow.

What is the current ratio of Rocket Pharmaceuticals Warrant (RCKTW)?

The current ratio of Rocket Pharmaceuticals Warrant (RCKTW) is 6.38, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Rocket Pharmaceuticals Warrant (RCKTW)?

The operating income of Rocket Pharmaceuticals Warrant (RCKTW) is -$231.7M. Learn about operating income.